Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|October 2, 1982
Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibodyR H Begent, P A Keep, A J Green, et al.
British Journal of Cancer|January 1, 1996
Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modificationC Delgado, R B Pedley, A Herraez, et al.
Biochimica Et Biophysica Acta|December 22, 1989
Identification of a human ribosomal protein mRNA with increased expression in colorectal tumoursK A Chester, L Robson, R H Begent, et al.
International Journal of Cancer|March 4, 2000
Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion proteinJ Bhatia, S K Sharma, K A Chester, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Treatment of small cell lung cancer by eight weeks chemotherapyS M Crawford, D Parker, M G Glaser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinomaM P Napier, S K Sharma, C J Springer, et al.
British Journal of Cancer|September 1, 1989
Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancerR H Begent, J A Ledermann, A J Green, et al.
The British Journal of Surgery|January 1, 1986
Radioimmunolocalization and selection for surgery in recurrent colorectal cancerR H Begent, P A Keep, F Searle, et al.
Immunotechnology : an International Journal of Immunological Engineering|February 1, 1996
In vitro and in vivo characterisation of a recombinant carboxypeptidase G2::anti-CEA scFv fusion proteinN P Michael, K A Chester, R G Melton, et al.
Pageof 13